Professional Documents
Culture Documents
As AESGP President, Roger SCARLETT-SMITH introduced the AESGPs new Self-Care Agenda 2020
which primarily addresses unnecessary restrictions
currently placed on developing self-care in Europe.
He outlined that industry had the opportunity to
give millions of people across the European Union
safe and effective access to self-care but for this to
happen there was a need for improving the regulatory system. People want to take responsibility for
their own health and this, combined with demographic changes and the increasing cost of professional healthcare, means more must be done to develop and support self-care.
To achieve greater self-care in Europe by the year
2020, the AESGP Agenda puts forward six
enablers: establishing evidence-based policies, fostering enhanced cooperation between all stakeholders, creating more incentives for innovation in
self-care, reducing administrative burden, using
procedures for market access efficiently and implementing existing rules reasonably.
Roger Scarlett-Smith
In a fast-changing and global environment, it is imperative that the regulatory system be fit for purpose, efficient and risk-based whilst ensuring optimum public health protection. Any formal evaluation of a regulatory instrument should include the
different actors involved (e.g. regulators, industry,
patient organisations, healthcare professionals). It
should also include feedback loops to ensure that
the instruments continue to operate well and remain fit for purpose.
There is an availability issue with non-prescription
medicines in Europe. It is shocking that only five
ingredients were available as non-prescription medicines in all EU Member States. The routes to market (centralised, mutual recognition, decentralised
Nicolas Bouzou
2
According to Nicolas BOUZOU, founder and director of Asters, the healthcare battle is a great way
to reconcile European citizens with scientific innovation because it can help solving human issues. The
Welfare State has been shaping the life of European
people. But the economic and technological environment has been changing quickly while the Welfare State is difficult to reform. European citizens are
getting older. Health expenses increase because of
the impact of chronic diseases like diabetes or cancer. Health expenditures are rising very quickly in
nearly all rich countries. Health is what economists
call a superior good, namely a good whose weight
in private incomes is rising.
Conference report
Francine Nieto
Conference report
Brian McNamara
Vincent Warnery
Boehringer has a perfect portfolio, 15 brands in four of Sanofis six priority categories and the merged entity
would be in the top five in the worlds 11 leading markets, including Japan and Greece. Warnery recognised
the great achievement of Boehringer.
Warnery highlighted two key factors of Sanofis future business model for growth. First, striking strategic
partnerships with prescription brand firms to fuel OTC switches is vital, noting Sanofis deal with Eli Lilly over
the erectile dysfunction drug Cialis (tadalafil). Secondly, "swap transactions" for brands or even whole portfolios will be key to create a win-win situation and to address 2 in 1 strategic objective. In conclusion, Warnery
confirmed Sanofi is highly motivated by the OTC market.
Birgit Schuhbauer
Babis Papadimitriou
Conference report
Suneet Varma
In France, everything is ready to increase the development of self-care rapidly: the patients, the health
care professionals, the distribution and control networks The only missing factor is a strong political
will to place self-care at the heart of a new health
care strategy. The lack of political anticipation on
these issues is difficult to understand. According to
Brossard, we must react and adopt an approach
which works everywhere else in the world. He concluded that Afipa was ready to support any political
action aiming to develop self-care.
Dirk Ossenberg-Engels
8
Karen Proud
Conference report
CHP Canada is working with pharmacy regulators to ensure that self-care remains the first response to
health care and has launched communication campaigns to the public. CHP Canada has been spreading
the word self-care and is working with Canadian politicians to increase awareness among Canadian officials of the value of formally recognising self-care as a primary component of the healthcare system and
providing the resources necessary to support the efforts of its citizens to practice responsible self-care.
Concluding on the session, Chair Suneet VARMA reminded that the true value of self-care needs to be
shown to policymakers, health insurances, consumers and the like, and while we say this every year, the
time is now to demonstrate the benefits.
distributed to pharmacies & health centers. Facebook was a key tool in this campaign as it allows
for speed and flexibility by contrast with leaflets
and factsheets. Since its launch, the programme
has been extended with a childrens game called
Learning about health is fun and a self-care
conference is also planned for the autumn 2016.
Michael Becker
10
Jan Smits
Conference report
priate non-prescription medicine for their patients. Last, she informed the audience about the
EPSA Training Project aiming at raising awareness
among students through webinars and fostering
the development of their soft-skills.
Following the same approach and promoting a
better interprofessional collaboration and education (with dentistry, psychology and medicine
students), Swiderek informed the audience that
EPSA collaborated with the other European health
care students associations.
Legislation, passed in May 2016, is expected to allow the sale of 216 out of 1582 non-prescription medicines outside Community Pharmacies. The average price of an OTC product being the lowest in Europe,
there is room for higher prices, still keeping in mind the sensitive economic and social situation of the
country. Although in theory competition in pricing should benefit the consumers, it may also give the
opposite results, leading to more expensive products and bigger risks for public health. He concluded by
warning the industry that if the situation gets worse, state-fixed prices and sales restrictions could easily
be re-established.
Digital strategies to
provide support to the
European citizens
Session chair Sophia FILAKTOU, Business & Industry Solutions at SAP, expressed her pleasure to
chair this session in her home country and introduced the speakers who would give insights into
the changes of consumer behaviour e.g. through
social media. What are the concrete implications
for the manufacturers of self-care products? How
to best develop a digital strategy which corresponds to market expectations?
Laurent Faracci
12
Sophia Filaktou
Conference report
@susitravel used as a platform for weekly conversation between pharmacists aiming at improving
advice to patients and increasing product sales.
Torrens concluded that pharmacist could offer
health and independent trustable advice online
and created a community around their brand.
Social media can be used to boost the community vitality.
Laurent CORAZZA, founder of DIGILITYX, explained that speed is key for a successful digital
business strategy. The development of the ehealth market shows that health care is becoming
digital. Instead of talking about a digital strategy,
Corazza preferred to talk about a digital roadmap
to achieve a sustainable and competitive advantage with digital capabilities. Sharing his own
experience, he listed four main factors that the
health industry should take into account to develop a digital strategy:
Explore data: data being tomorrows petroleum, collecting and processing data is essential to understand the needs of the actors
and to integrate the new technological capabilities
Think deep digital: Make sure that your internal processes are aligned with your digital
objectives (full dematerialisation).
13
Laurent Corazza
Branding self-care
Roger SCARLETT-SMITH, AESGP President, introduced the session recalling brands are the major asset of
the self-care industry; 80% of consumers choose their OTC products based on their brand name in Europe.
He reiterated industry support for umbrella branding, noting that it was clear that consumers were used to
interpreting and reading the label" and using brands as navigation. In line with its self-care Agenda 2020,
AESGP will continue to work with regulators to support umbrella branding, Introducing the speakers, Scarlett-Smith asked them how brand communication can evolve in the age of new technologies.
Briain de Buitleir
14
Briain DE BUITLEIR, CEO of PGT Healthcare, presented the joint-venture combining the two companies Procter&Gamble and Teva to allow a better
growth by synergy of the two parent companies
and of the culture dedicated to brands. To be successful, brands must put consumer at the centre.
To create a brand, there must be a belief that have
an important social purpose (referring to ratiopharm and Swisse), a distinctive proposition, a
product that delivers (repeat rate number on the
market like Swisse) and capabilities to make it real
(investments and commitments).
Conference report
Michael Popp
15
John Chave
Hubertus Cranz
16
Conference report
The AESGP OTC Ingredients Directory compares the classification status (prescription or
non-prescription) of key active pharmaceutical ingredients used in self-care in 39 countries (25 European and 14 non-European).
It is based on information provided by WSMI
and AESGP member associations and is
widely recognised as the most comprehensive analysis in this context.
Lars Ritter
17
Jurate SVARCAITE, Secretary General of the Pharmaceutical Group of the European Union (PGEU)
congratulated Ritter for the important legislative
work done on the very challenging and broad category of products covered by the definition of medical devices.
Noting that medical devices had been one of the
most innovative sectors in self-care, she pointed out
that pharmacists were still building trust in these
products as they were still more comfortable with
the regulatory framework applicable to medicinal
products. As healthcare professionals, Svarcaite said
that pharmacists were highly interested in the medical devices requirements regarding pharmacovigilance or any regulated activities allowing detection,
assessment, understanding and prevention of medical devices related issues.
Alexandra Nikolakopoulou
18
Jurate Svarcaite
Conference report
Innovation in self-care in
Europe - Update from a Medicines
Regulatory Agency
June RAINE, Chair of the European Medicines
Agency (EMA)s Pharmacovigilance Risk Assessment Committee (PRAC) and Director of Vigilance and Risk Management of Medicines at the
Medicines Healthcare products Regulatory Agency
(MHRA) of the United Kingdom, started her presentation by referring to the definition by default
of the non-prescription legal status; the natural
legal status is pharmacy unless active decision ta-
June Raine
19
Conference report
Nikos Vettas
21
Laurent Alexandre
53rd AESGP
Annual Meeting
Vienna
30 May - 1 June 2017